- Home
- ATGL vs NBP Comparison
ATGL vs NBP Comparison
Compare ATGL & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATGL | NBP |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | Hong Kong | United States |
| Employees | N/A | 30 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 241.3M | 225.5M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATGL | NBP |
|---|---|---|
| Price | $11.00 | $1.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 1.3K | ★ 780.1K |
| Earning Date | 01-27-2026 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.01 | $1.46 |
| 52 Week High | $50.00 | $5.19 |
Technical Indicators
Market Signals| Indicator | ATGL | NBP |
|---|---|---|
| Relative Strength Index (RSI) | 37.70 | 52.94 |
| Support Level | $10.52 | $1.67 |
| Resistance Level | $16.08 | $1.95 |
| Average True Range (ATR) | 0.82 | 0.17 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 8.49 | 51.89 |
Price Performance
Historical ComparisonAbout ATGL Alpha Technology Group Limited
Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.
About NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.